Literature DB >> 8264661

Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity.

P Aza-Blanc1, R Di Lauro, P Santisteban.   

Abstract

The mechanism for hormonal regulation of rat thyroperoxidase (rTPO) gene transcription in rat FRTL-5 thyroid cells has been investigated. Transient transfection experiments demonstrate that the minimal rTPO promoter that confers thyroid-specific expression also confers responsiveness to TSH and insulin. TSH induces a 7-fold increase in promoter activity, and the induction is detected almost immediately after the addition of the hormone. Insulin also stimulates TPO promoter activity, but the effect of this hormone is weaker and slower than that of TSH. The effect of TSH in increasing TPO promoter activity is mimicked by the cAMP agonist forskolin. The calcium-protein kinase C pathway is also involved in the regulation of the rTPO promoter activity, since a calcium ionophore (A23187) and phorbol esters [12-O-tetradecanoyl-phorbol-13-acetate (TPA)] inhibit it quickly. These data indicate that the region of the rTPO promoter used here contains the DNA signals necessary for its hormonal regulation. Protein-DNA binding studies show that the thyroid-specific nuclear protein TTF-2, which binds to the rTPO promoter, is induced by TSH and forskolin, and this effect is clearly observable as early as 5 h post induction. Moreover, the DNA binding activity of TTF-2 is inhibited by both A23187 and TPA. Heterologous promoter constructs containing four, eight, or 12 tandem repeats of an oligonucleotide that includes the TTF-2 binding site increase their activity in response to TSH, forskolin, and insulin, while the the presence of A23187 or TPA inhibits their activity. These data indicate that the TTF-2 protein plays an important role in the hormonal control of thyroid-specific transcription.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264661     DOI: 10.1210/mend.7.10.8264661

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

1.  DARPP-32 is required for MAPK/ERK signaling in thyroid cells.

Authors:  Ana Chocarro-Calvo; Miguel A Zaballos; Pilar Santisteban; Custodia García-Jiménez
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  Thyroid development and effect on the nervous system.

Authors:  Pilar Santisteban; Juan Bernal
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

3.  TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation.

Authors:  M Zannini; V Avantaggiato; E Biffali; M I Arnone; K Sato; M Pischetola; B A Taylor; S J Phillips; A Simeone; R Di Lauro
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  DuOx2 Promoter Regulation by Hormones, Transcriptional Factors and the Coactivator TAZ.

Authors:  L C Cardoso-Weide; R C Cardoso-Penha; M W Costa; A C F Ferreira; D P Carvalho; P S Santisteban
Journal:  Eur Thyroid J       Date:  2015-03-07

5.  Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.

Authors:  Andrey Bychkov; Vladimir Saenko; Masahiro Nakashima; Norisato Mitsutake; Tatiana Rogounovitch; Alyaksandr Nikitski; Florence Orim; Shunichi Yamashita
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

6.  A novel FOXE1 mutation (R73S) in Bamforth-Lazarus syndrome causing increased thyroidal gene expression.

Authors:  Aurore Carré; Rasha T Hamza; Dulanjalee Kariyawasam; Loïc Guillot; Raphaël Teissier; Elodie Tron; Mireille Castanet; Corinne Dupuy; Mohamed El Kholy; Michel Polak
Journal:  Thyroid       Date:  2014-01-23       Impact factor: 6.568

7.  The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure.

Authors:  Isabel Cuesta; Kenneth S Zaret; Pilar Santisteban
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

8.  Purification and characterization of thyroid transcription factor 2.

Authors:  D Civitareale; A Saiardi; P Falasca
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

9.  Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.

Authors:  Sara Salehi Hammerstad; Jason T Blackard; Angela Lombardi; Randall P Owen; Erlinda Concepcion; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

10.  The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.

Authors:  Iñigo Landa; Sergio Ruiz-Llorente; Cristina Montero-Conde; Lucía Inglada-Pérez; Francesca Schiavi; Susanna Leskelä; Guillermo Pita; Roger Milne; Javier Maravall; Ignacio Ramos; Víctor Andía; Paloma Rodríguez-Poyo; Antonino Jara-Albarrán; Amparo Meoro; Cristina del Peso; Luis Arribas; Pedro Iglesias; Javier Caballero; Joaquín Serrano; Antonio Picó; Francisco Pomares; Gabriel Giménez; Pedro López-Mondéjar; Roberto Castello; Isabella Merante-Boschin; Maria-Rosa Pelizzo; Didac Mauricio; Giuseppe Opocher; Cristina Rodríguez-Antona; Anna González-Neira; Xavier Matías-Guiu; Pilar Santisteban; Mercedes Robledo
Journal:  PLoS Genet       Date:  2009-09-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.